TP53 and pancreatic adenocarcinoma: Moreover, the mutation data analysis of the TCGA-PAAD cohort showed that missense mutations, SNPs, and C>T accounted for a large proportion of TP53 mutations, which with a high mutation rate of 63% (Figure 8F).